Search

Home > Talking Biotech Podcast > Biotech and Tick Vectored Disease
Podcast: Talking Biotech Podcast
Episode:

Biotech and Tick Vectored Disease

Category: Science & Medicine
Duration: 00:32:51
Publish Date: 2022-02-26 19:08:50
Description:

Ticks are significant disease vectors, with an emerging scope of pathologies associated with tick bites. New technologies have accelerated the ability to genetically engineer ticks, creating new opportunities to understand gene function in ticks, as well as potentially use gene editing to control numbers or affect disease vectoring. Dr. Monika Gulia-Nuss (University of Nevada, Reno) and Dr. Jason Rasgon (Penn State University) describe tick disease transmission, new transformation technology, and potential applications.  


# COLABRA

Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/

# TALKING BIOTECH

Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq

The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.

Total Play: 0